NCT07579091

Brief Summary

The maxillary bones and the nasal septum are interconnected structures. The nasal septum acts as a growth center that facilitates normal maxillofacial growth and development. The objective of this study is to evaluate the presence or absence of septal deviation, as well as its degree of severity, within two adult population groups with or without maxillary transverse deficiency. This is a retrospective CT scan study. While several studies have been conducted in this field, our study is original in its approach to: maxillary transverse deficiency as a measure of the transverse dimension of the maxilla, the use of CT scans as the radiological medium for evaluating the primary endpoint, and finally, the specific method used to measure septal deviation. If a correlation exists between the two, it would be interesting to investigate whether maxillary transverse deficiency leads to septal deviation, or if septal deviation contributes to maxillary deficiency through nasal obstruction. This could highlight the importance of early management of both maxillary transverse deficiency and nasal obstruction. In adult patients, it could support the idea of performing a single combined procedure involving maxillary expansion and septoplasty, which would reduce comorbidities and risks; ultimately representing a true benefit for the patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
223

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 7, 2026

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2026

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2026

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

April 29, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 11, 2026

Completed
Last Updated

May 11, 2026

Status Verified

April 1, 2026

Enrollment Period

1 month

First QC Date

April 29, 2026

Last Update Submit

May 6, 2026

Conditions

Keywords

transverse maxillary deficiencyendognathiaseptal deviationCT scannasal septal deviation

Outcome Measures

Primary Outcomes (1)

  • Nasal septal deviation measured by coronal CT scan

    one day

Secondary Outcomes (6)

  • Width of the piriform apertures measured by coronal CT scan

    one day

  • Depth of the palatal vault measured by sagittal CT scan

    one day

  • location of the septal deviation measured by coronal CT scan

    one day

  • degree of septal deviation and depth of the palatal vault

    one day

  • width of the piriform apertures and depth of the palatal vault

    one day

  • +1 more secondary outcomes

Study Arms (2)

Patient with maxillary transverse deficiency

Patient with maxillary constriction

Patient without maxillary transverse deficiency

Patient without maxillary constriction

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Deceased from natural causes and underwent a whole-body CT scan between 2010 and 2017, in the State of New Mexico (USA)

You may qualify if:

  • Adult with completed growth (\> 18 years old)
  • Deceased from natural causes and underwent a whole-body CT scan between 2010 and 2017, in the State of New Mexico (USA)
  • Presence of maxillar and mandibular teeth from first molar to first molar (from 6 to 6)
  • No body decomposition at the time of the CT scan

You may not qualify if:

  • History of maxillofacial surgery or trauma
  • Congenital craniofacial pathologies or anomalies
  • Presence of maxillary or mandibular orthodontic appliances (or retainers)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Delcampe

Nancy, 54000, France

Location

Study Officials

  • Bart Vande Vannet

    Central Hospital, Nancy, France

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PuPh

Study Record Dates

First Submitted

April 29, 2026

First Posted

May 11, 2026

Study Start

February 7, 2026

Primary Completion

March 10, 2026

Study Completion

April 7, 2026

Last Updated

May 11, 2026

Record last verified: 2026-04

Locations